Journal of Public Health Policy

, Volume 30, Issue 2, pp 127–143

Medication-associated diethylene glycol mass poisoning: A review and discussion on the origin of contamination

  • Joshua G Schier
  • Carol S Rubin
  • Dorothy Miller
  • Dana Barr
  • Michael A McGeehin
Original Article


Diethylene glycol (DEG), an extremely toxic chemical, has been implicated as the etiologic agent in at least 12 medication-associated mass poisonings over the last 70 years. Why DEG mass poisonings occur remains unclear. Most reports do not contain detailed reports of trace-back investigations into the etiology. The authors, therefore, conducted a systematic literature review on potential etiologies of these mass poisonings. The current available evidence suggests that substitution of DEG or DEG-containing compounds for pharmaceutical ingredients results from: (1) deception as to the true nature of certain ingredients by persons at some point in the pharmaceutical manufacturing process, and (2) failure to adhere to standardized quality control procedures in manufacturing pharmaceutical products intended for consumers. We discuss existing guidelines and new recommendations for prevention of these incidents.


diethylene glycol mass poisoning poisoning 


  1. Geiling, E.M.K. and Cannon, P.R. (1938) Pathologic effects of elixir of sulfanilamide (diethylene glycol) poisoning. JAMA 111: 919–926.CrossRefGoogle Scholar
  2. Leech, P.N. (1937) Elixir of Sulfanilamide-Massengill. Chemical pharmacologic pathologic and necropsy reports; preliminary toxicity reports on diethylene glycol and sulfanilamide. JAMA 109: 1531–1539.CrossRefGoogle Scholar
  3. History of the FDA: The 1938 Food, Drug and Cosmetics Act,, accessed 8 December 2008.
  4. Pandya, S.K. (1988) An unmitigated tragedy. British Medical Journal 297: 117–120.CrossRefGoogle Scholar
  5. Bowie, M.D. and McKenzie, D. (1972) Diethylene glycol poisoning in children. South African Medical Journal: 931–934.Google Scholar
  6. Okuonhghae, H.O., Ighogboja, I.S., Lawson, J.O. and Nwana, E.J.C. (1992) Diethylene glycol poisoning in Nigerian children. Annals of Tropical Paediatrics 12: 235–238.CrossRefGoogle Scholar
  7. Hanif, M., Mobarak, M.R., Ronan, A., Rahman, D., Donovan Jr., J.J. and Bennish, M.L. (1995) Fatal renal failure caused by diethylene glycol in paracetamol elixir: The Bangladesh epidemic. BMJ 311: 88–91.CrossRefGoogle Scholar
  8. Cantarell, M.C., Fort, J., Camps, J., Sans, M. and Piera, L. (1987) Acute intoxication due to topical application of diethylene glycol. Annals of Internal Medicine 106: 478–479.CrossRefGoogle Scholar
  9. Drut, R., Quijano, G., Jones, M.C. and Scanferla, P. (1994) Hallazgos patologicos en la intoxicacion por dietilenglicol. Medicina (Buenos Aires) 54: 1–5.Google Scholar
  10. Ferrari, L.A. and Giannuzzi, L. (2005) Clinical parameters postmortem analysis and estimation of lethal dose in victims of a massive intoxication with diethylene glycol. Forensic Science International 153: 45–51.CrossRefGoogle Scholar
  11. O’Brien, K.L. et al (1995) Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. JAMA 279: 1175–1180.CrossRefGoogle Scholar
  12. Singh, J. et al (2001) Diethylene glycol poisoning in Gurgaon, India 1998. Bulletin of the World Health Organization 79: 88–95.Google Scholar
  13. Hari, P., Jain, Y. and Kabra, S.K. (2006) Fatal encephalopathy and renal failure caused by diethylene glycol poisoning. Journal of Tropical Pediatrics 52: 442–444.CrossRefGoogle Scholar
  14. Junod, S.W. (2000) Diethylene glycol deaths in Haiti. Public Health Reports 115: 78–86.CrossRefGoogle Scholar
  15. Schier, J.G. and Algren, A. (2007) Medical toxicology and public health – Update on research and activities at the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Journal of Medical Toxicology 3: 85–86.CrossRefGoogle Scholar
  16. The CNA Corporation. After action report on HHS's response to the 2006 diethylene glycol poisonings in the Republic of Panama. IPR 12272/Draft, March 2007.Google Scholar
  17. (2004) Pilosuryl and severe diethylene glycol intoxication. Prescrire International 13: 99.Google Scholar
  18. Calvery, H.O. and Klumpp, T.G. (1939) The toxicity for human beings of diethylene glycol with sulfanilamide. Southern Medical Journal 32: 1105–1109.CrossRefGoogle Scholar
  19. Barr, D.B. et al (2007) Identification and quantification of diethylene glycol in pharmaceuticals implicated in poisoning epidemics: An historical laboratory perspective. Journal of Analytical Toxicology 31: 295–303.CrossRefGoogle Scholar
  20. Overkamp, K.M., Bakker, B.M., Kotter, P., Luttik, M.A.H., Van Dijken, J.P. and Pronk, J.T. (2002) Metabolic engineering of glycerol production in Saccharomyces cerevisiae. Applied and Environmental Microbiology 68: 2814–2821.CrossRefGoogle Scholar
  21. Cockburn, R., Newton, P.N., Agyarko, E.K., Akunyili, D. and White, N.J. (2005) The global threat of counterfeit drugs: Why industry and governments must communicate the dangers. PLoS Medicine 2 (4): e100, (Epub 2005, 14 March).CrossRefGoogle Scholar
  22. Jungermann, E. and Sonntag, N.O.V. (eds.) (1991) Glycerine: A Key Cosmetic Ingredient. New York: Marcel Dekker.Google Scholar
  23. Rehm, H.J. (2001) Microbial Production of Glycerol and other Polyols. In: H.J. Rehm, G. Reed, A. Pühler and P. Stadler (eds.) Biotechnology 2001, 2nd edn. New York: Wiley-VCH Publishing.Google Scholar
  24. Wang, Z.X., Zhuge, J., Fang, H. and Prior, B.A. (2001) Glycerol production by microbial fermentation: A review. Biotechnology Advances 19: 201–223.CrossRefGoogle Scholar
  25. Spencer, J.F.T. and Spencer, D.M. (1978) Production of Polyhydroxy Alcohols by Osmotolerant Yeasts. In: A.H. Rose (ed.) Economic Microbiology, Vol. 2. London: Academic Press.Google Scholar
  26. Harbison, R.D. (1998) Alcohols and Glycols. In: R.D. Harbison (ed.) Hamilton and Hardy's Industrial Toxicology, 5th edn. New York: Mosby, pp. 217–235.Google Scholar
  27. The Innovation Group. Propylene glycol,, accessed 6 April 2007.
  28. Shell Chemicals. Product overview. Propylenel glycol,,1098,1510,00.html, accessed 10 April 2007.
  29. ATSDR. Toxicological profile for ethylene glycol and propylene glycol,, accessed 3 April 2007.
  30. World Health Organization. (1998) General policy issues. WHO Drug Information 12: 129–135.Google Scholar
  31. Bogdanich, W. and Hooker, J. From China to Panama a trail of poisoned medicine,, accessed 5 September 2007.
  32. United States Food and Drug Administration – Forensic Chemistry Center. (1996) Report on Haitian Samples – Preliminary Results, 31 October.Google Scholar
  33. Baffi, P., Elneser, S., Baffi, M. and De Melin, M. (2000) Quantitative determination of diethylene glycol contamination in pharmaceutical products. Journal of AOAC International 83: 793–801.Google Scholar
  34. Taherzadeh, M.J., Adler, L. and Liden, G. (2002) Strategies for enhancing fermentative production of glycerol – A review. Enzyme and Microbial Technology 31: 53–66.CrossRefGoogle Scholar
  35. Biebl, H. (2001) Fermentation of glycerol by Clostridium pasteurianum – Batch and continuous culture studies. Journal of Industrial Microbiology and Biotechnology 27: 18–26.CrossRefGoogle Scholar
  36. Cronwright, G.R., Rohwer, J.M. and Prior, B.A. (2002) Metabolic control analysis of glycerol synthesis in Saccharomyces cerevisiae. Applied and Environmental Microbiology 68: 4448–4456.CrossRefGoogle Scholar
  37. Remize, F., Roustan, J.L., Sablayrolles, J.M., Barre, P. and Dequin, S. (1999) Glycerol overproduction by engineered Saccharomyces cerevisiae wine yeast strains leads to substantial changes in by-product formation and to a stimulation of fermentation rate in stationary phase. Applied and Environmental Microbiology 65: 143–149.Google Scholar
  38. Dow. Product safety: Propylene glycol,, accessed 6 April 2007.
  39. Boganich, W. Chinese chemicals flow unchecked onto world drug market, 2007/10/31/world/asia/31chemical|.html?_r=1&ex=1194667200&en=e80f8502f76576d3&ei=5070&emc=eta1&oref=slogin, accessed 17 November 2007.
  40. About USP: An overview,, accessed 3 April 2007.
  41. Title 21: Food and Drugs. Chapter I – Food and Drug Administration, Department of Health and Human Services. Part 211 – Current good manufacturing practices for finished pharmaceuticals,, accessed 3 April 2007.
  42. US Code Home – Title 21: Food and Drugs,, accessed 3 April 2007.Google Scholar
  43. British Pharmacopoeia. (2007), accessed 3 April 2007.
  44. FDA. Drug application approval 501(b) policy,, accessed 19 April 2007.
  45. FDA. Part 211 – Current good manufacturing practice for finished pharmaceuticals,, accessed 11 June 2007.
  46. United States Food and Drug Administration. Guidance for industry testing of glycerin for diethylene glycol,, accessed 8 December 2008.
  47. WHO. Good Manufacturing Practices: Main principles for pharmaceutical products,, accessed 3 April 2007.
  48. WHO. Control and safe trade of starting materials for pharmaceutical products,, accessed 3 April 2007.
  49. Kei Kishimoto, T., Viswanathan, K. and Ganguly, T. et al (2008) Contaminated heparin associated with adverse clinical events and activation of the contact system. New England Journal of Medicine 358: 2457–2467.CrossRefGoogle Scholar

Copyright information

© Palgrave Macmillan 2009

Authors and Affiliations

  • Joshua G Schier
    • 1
  • Carol S Rubin
    • 1
  • Dorothy Miller
    • 2
  • Dana Barr
    • 3
  • Michael A McGeehin
    • 1
  1. 1.Division of Environmental Hazards and Health EffectsNational Center for Environmental Health, Centers for Disease Control and PreventionAtlantaUSA
  2. 2.United States Food and Drug AdministrationRockvilleUSA
  3. 3.Division of Laboratory SciencesNational Center for Environmental Health, Centers for Disease Control and PreventionAtlantaUSA

Personalised recommendations